Therapy: Assessing cancer risk of cytokine inhibitors in RA

Nat Rev Rheumatol. 2010 Mar;6(3):126-7. doi: 10.1038/nrrheum.2010.21.
No abstract available

Publication types

  • News

MeSH terms

  • Adolescent
  • Antibodies, Monoclonal / adverse effects*
  • Antirheumatic Agents / adverse effects*
  • Arthritis, Rheumatoid / drug therapy*
  • Arthritis, Rheumatoid / epidemiology
  • Child
  • Comorbidity
  • Dose-Response Relationship, Drug
  • Humans
  • Neoplasms / epidemiology
  • Neoplasms / etiology*
  • Risk Assessment
  • Risk Factors
  • Sweden / epidemiology

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents